Goals of Care Conversations Training for Seriously Ill Patients
(LSTDI Trial)
Trial Summary
What is the purpose of this trial?
The long term goal is to improve quality of care in Veterans with serious illnesses by aligning medical care with Veterans' goals and values. The objective of this study is to use a sequentially randomized trial to determine what implementation strategies are effective to increase early, outpatient goals of care conversations. The study will use interviews with and surveys of medical providers, patients, and caregivers, along with medical record data. This work is significant because it tests ways Veterans can express their goals and preferences for life sustaining treatments and have them honored.
Research Team
David Bekelman, MD MPH
Principal Investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
Anne M Walling, MD PhD
Principal Investigator
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Eligibility Criteria
This trial is for Veterans with serious illnesses like cancer, heart failure, lung diseases, kidney or liver failure, and dementia. They must be enrolled in VHA healthcare at one of the study sites and have a high risk of hospitalization or death within a year. Clinicians eligible are those who need to improve their skills in discussing care goals with patients.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Clinician Implementation Strategy Stage 1 (Behavioral Intervention)
- Clinician Implementation Strategy Stage 2 (Behavioral Intervention)
- High patient engagement (Behavioral Intervention)
- Low patient engagement (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Dr. Grant Huang
VA Office of Research and Development
Acting Chief Research and Development Officer
PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences
Dr. Erica M. Scavella
VA Office of Research and Development
Chief Medical Officer since 2022
MD from University of Massachusetts School of Medicine